After several medical battles, Armond Armstead finally announces his retirement
|07.16.14 at 3:39 pm ET|
The mystery over Armond Armstead has ended in retirement.
The 23-year-old defensive tackle originally signed with the Patriots on Feb. 1, 2013, after one season with the Toronto Argonauts. The 6-foot-5, 305-pounder, who was brought in as potential depth along the defensive line, was placed on the Reserve/Non-Football Injury List on Aug. 26, 2013.
There was plenty of speculation about his future in New England before the move to place him on the NFI list and over the course of this offseason, including OTAs and minicamp.
But all of that ended Wednesday, eight days before the opening of full training camp. as it turned out, Armstead could never fully recover after surgery on July 29, 2013 to treat an undisclosed infection.
“It has been a pleasure being around Armond, as he gave everything he could to play for us,” Patriots coach Bill Belichick said Wednesday in a team-issued statement. “Armond worked extremely hard since joining us last February. He’s had a lot of adversity personally that he’s had to deal with, unusual compared to most other players, but he’s always had a great attitude, worked hard and really did everything we asked him to do.
“While it is unfortunate he will not be able to play football, Armond is an outstanding young man who has a very bright future in whatever path he chooses.”
Armstead played for the Toronto Argonauts of the Canadian Football League after signing with the team as an undrafted free agent in 2012 out of the University of Southern California. He compiled 43 tackles, two special teams tackles and six sacks with Toronto. He was also named to the CFL All-Star game and helped Toronto win the Grey Cup. He started in 24 games at USC from 2008 through 2010.
Armstead suffered a heart attack while playing for USC, a medical event which he has blamed on unsolicited injections of the pain medication Toradol. That led to a lawsuit against the USC team physician, University Park Health Center, and an unnamed pharmaceutical company for unspecified damages, claiming the improperly administered Toradol injections caused the heart attack and affected his NFL career.
Latest from Bleacher Report
- What We've Learned Through Week 2 of Pats Preseason
- Previewing Patriots' Preseason Week 3 Matchup
- Patriots Preseason Week 2 Stock Report
- Report: Edelman's Wk 1 Status Uncertain
- Is Signing Wayne a Smart Move for Pats?
- NFL Files Letter in Response to Brady's Case Examples
- Even with Empty Tank, Wayne Fits with Pats